Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.4M | 3.3M | 1.62 |
| 2025-03-31 | $6.4M | 5.6M | 1.16 |
| 2024-12-31 | $4.6M | 4.3M | 1.07 |
| 2024-09-30 | $3.8M | 3.3M | 1.17 |
| 2024-06-30 | $7.4M | 6.9M | 1.08 |
| 2024-03-31 | $1.1M | 1.2M | 0.94 |
| 2023-12-31 | $114k | 115k | 0.99 |
| 2023-09-30 | $492k | 530k | 0.93 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1